ImmPRINT

On Monday, September 11, 2023, the FDA took action authorizing and approving the updated 2023-2024 monovalent XBB.1.5 variant mRNA COVID-19 vaccines by Moderna and Pfizer-BioNTech. On September 12, 2023, CDC recommended use of these updated 2023-2024 COVID-19 vaccines in all individuals ages 6 months or older. With these FDA and CDC actions, the CDC COVID-19 Vaccination Program is discontinued. Bivalent Moderna and Pfizer-BioNTech mRNA COVID-19 vaccines should no longer be administered.

The US Government is no longer purchasing COVID-19 vaccines for distribution through the CDC COVID-19 Vaccination Program. Providers will need to directly purchase doses of the updated 2023-2024 COVID-19 vaccines and administer them through their standard processes outside the discontinued CDC COVID-19 Vaccination Program.

ImmPRINT

Immunization Patient Registry with Integrated Technology (ImmPRINT) is a statewide population-based information system for all children born in Alabama since January 1, 1993 and adults.

If you are a healthcare provider, school, child care center, or pharmacy and want to enroll, please choose this link if you have questions: [email protected] .

ImmPRINT Enrollment Benefits

Data Exchange

Questions a provider is supposed to ask their EHR vendor prior to picking an EHR

ADPH has been requested by Alabama providers statewide to supply the list of EHR vendors who have signed the Data Sharing Agreement (DSA) for HL7 onboarding. ADPH is not endorsing any vendors, but simply providing the requested list. Since September 2016, the following vendors have signed the DSA and established unidirectional or bidirectional interface. Please click here to view the list.

ImmPRINT Meaningful Use (MU)

Declaration of Readiness for Modified Stage 2 and Stage 3 Meaningful Use (MU)

Readiness Statement
ImmPRINT accepts electronic immunization data submissions from Eligible Professionals’ (EPs) and Eligible Hospitals’ (EHs) certified electronic health record (EHR), to fulfill the Medicaid EHR Incentive Program and the MIPS Advancing Care Information Quality Payment Program for Public Health MU Reporting Objective - Immunization Registry Reporting.

Therefore, no Alabama EPs or EHs administering vaccines can receive exclusion to the Public Health Reporting MU Objective- Immunization Registry Reporting.

ImmPRINT accepts MU Exchange Standards listed below:
· MU Modified Stage 2 HL7 Version 2.5.1
· MU Stage 3 HL7 Version 2.5.1

ImmPRINT currently is accepting Query/Response, Acknowledgement Messages, and National Drug Codes (NDC) for encountered vaccines. ImmPRINT utilizes the CDC HL7 2.5.1 Implementation Guide for Immunization Messaging, Release 1.5 and Addendum.

ADPH has been requested by Alabama providers statewide to supply the list of EHR vendors who have signed the Data Sharing Agreement (DSA) for HL7 onboarding. ADPH is not endorsing any vendors, but simply providing the requested list. Since September 2016, the following vendors have signed the DSA and established unidirectional or bidirectional interface. Please click here to view the list.

Special Notes

ImmPRINT Resources

Page last updated: August 30, 2024